Related references
Note: Only part of the references are listed.Soluble Aβ42 Acts as Allosteric Activator of the Core Cholinergic Enzyme Choline Acetyltransferase
Amit Kumar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
CSF ApoE predicts clinical progression in nondemented APOEε4 carriers
Argonde C. van Harten et al.
NEUROBIOLOGY OF AGING (2017)
Amino-Terminal β-Amyloid Antibody Blocks β-Amyloid-Mediated Inhibition of the High-Affinity Choline Transporter CHT
Leah K. Cuddy et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs
Rajnish Kumar et al.
BRAIN (2016)
82-kDa choline acetyltransferase and SATB1 localize to β-amyloid induced matrix attachment regions
Warren Winick-Ng et al.
SCIENTIFIC REPORTS (2016)
Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains
Thomas J. Esparza et al.
SCIENTIFIC REPORTS (2016)
Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β
Mark L. Cohen et al.
BRAIN (2015)
Efficacy of Donepezil for Cognitive Impairments in Familial Hypercholesterolemia: Preclinical Proof of Concept
Jadna Bogado Lopes et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Michael Willem et al.
NATURE (2015)
High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia
Swetha Vijayaraghavan et al.
ALZHEIMERS & DEMENTIA (2014)
Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors
Taher Darreh-Shori et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
Linn Malmsten et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event?
Eduardo Luiz Gasnhar Moreira et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
V. K. Ramanan et al.
MOLECULAR PSYCHIATRY (2014)
Nuclear 82-kDa choline acetyltransferase decreases amyloidogenic APP metabolism in neurons from APP/PS1 transgenic mice
Shawn Albers et al.
NEUROBIOLOGY OF DISEASE (2014)
APP Homodimers Transduce an Amyloid-β-Mediated Increase in Release Probability at Excitatory Synapses
Hilla Fogel et al.
CELL REPORTS (2014)
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
Ting Yang et al.
ALZHEIMERS & DEMENTIA (2013)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
Brain amyloid-β oligomers in ageing and Alzheimer's disease
Sylvain E. Lesne et al.
BRAIN (2013)
Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease
Taher Darreh-Shori et al.
NEUROBIOLOGY OF AGING (2013)
Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway
Swetha Vijayaraghavan et al.
PLOS ONE (2013)
Inhibition of Choline Acetyltransferase as a Mechanism for Cholinergic Dysfunction Induced by Amyloid-β Peptide Oligomers
Nilson Nunes-Tavares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
Cholesterol Level and Statin Use in Alzheimer Disease II. Review of Human Trials and Recommendations
Nina E. Shepardson et al.
ARCHIVES OF NEUROLOGY (2011)
Disconnection of Frontal and Parietal Areas Contributes to Impaired Attention in Very Early Alzheimer's Disease
Susanne Neufang et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo
Taher Darreh-Shori et al.
NEUROBIOLOGY OF AGING (2011)
The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase
Taher Darreh-Shori et al.
NEUROBIOLOGY OF AGING (2011)
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Jae-Eun Kang et al.
SCIENCE (2009)
Amyloid-cholinesterase interactions - Implications for Alzheimer's disease
Nibaldo C. Inestrosa et al.
FEBS JOURNAL (2008)
Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro
E. Podoly et al.
NEURODEGENERATIVE DISEASES (2008)
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE ε4 allele, in relation to cognitive function and cerebral glucose metabolism
T. Darreh-Shori et al.
NEUROBIOLOGY OF DISEASE (2006)
Butyrylcholinesterase attenuates amyloid fibril formation in vitro
Sophia Diamant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
S Barghorn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oligomers in the brain: The emerging role of soluble protein aggregates in neurodegeneration
DM Walsh et al.
PROTEIN AND PEPTIDE LETTERS (2004)
Temporal alterations in cerebrospinal fluid amyloid β-p0rotein and apolipoprotein E after subarachnoid hemorrhage
A Kay et al.
STROKE (2003)
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
T Rees et al.
NEUROBIOLOGY OF AGING (2003)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Phosphorylation of 69-kDa choline acetyltransferase at threonine 456 in response to amyloidβ peptide 1-42
T Dobransky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Aβ toxicity in Alzheimer's disease:: globular oligomers (ADDLs) as new vaccine and drug targets
WL Klein
NEUROCHEMISTRY INTERNATIONAL (2002)
Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies
MP Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease
DJ Lehman et al.
HUMAN GENETICS (2000)
Share Paper
